University Staff Directory The University of Adelaide Australia
Faculties & Divisions | People A to Z | Media Expertise | Phonebook
Public browsing [Login]
Text Zoom: S | M | L

Dr Lisa Moran

Telephone +61 8 8313 1352
Position Research Fellow
Email lisa.moran@adelaide.edu.au
Fax +61 8 8313 1355
Building WCH - Norwich Centre
Floor/Room G 14
Campus Womens & Childrens Hospital
Org Unit Paediatrics and Reproductive Health

To link to this page, please use the following URL:
http://www.adelaide.edu.au/directory/lisa.moran

Biography/ Background

Robinson Institute, Discipline of Obstetrics and Gynaecology, The University of Adelaide

Women’s Public Health Research, School of Public Health and Preventive Medicine, Monash University

BSc (Hons), BND, PhD

 

Dr Lisa Moran is a National Heart Foundation post-doctoral research fellow at the Robinson Institute, Discipline of Obstetrics and Gynaecology, University of Adelaide and an adjunct staff member of Women’s Public Health Research, School of Public Health and Preventive Medicine, Monash University. Dr Moran has a background in basic science, molecular biology and physiology and clinical dietetics and a professional qualification as a dietician.

Qualifications

Bachelor of Science (Honours)

Bachelor of Nutrition and Dietetics

PhD

Awards & Achievements

2013:   South Australian Tall Poppy Award

2012:   First runner up, Medicine and Medical Sciences, Scopus Young Researchers Award

2012:   Post-graduate Australian Nutrition Trust Foundation travel scholarship

2012:   Heart Foundation Cardiovascular Research Development Program Fellowship

2011:   Finalist, Australia and New Zealand Society for the Study of Obesity National Conference Best Presentation

2011:   Finalist, South Australia Tall Poppy Award

2010:   Most Outstanding Early Career Researcher (University of Adelaide, Discipline of Obstetrics and Gynaecology)

2010:   Highly commended poster award, Southern Health Research Week

2010:   Travel Grant (Heart Foundation of Australia)

2009-12: Finalist, L’Oreal Australian For Women in Science Fellowship

2009:   Australia and New Zealand Society for the Study of Obesity Young Investigator Award

2008:   NHMRC Australian Biomedical Post-Doctoral Fellowship

2007:   Finalist, Endocrine Society of Australia Fellowship

2007:   The Jean Hailes Research Fellowship, Post-Doctoral Fellowship at The Jean Hailes Research            Institute, Monash Institute of Health Services Research, Monash University

2006:   Robert Seamark Postgraduate Award (University of Adelaide, Discipline of Obstetrics and

            Gynaecology)

2005:   Travel scholarship (Nutrition Society of Australia National Conference)

2005:   Travel Grant (Heart Foundation of Australia)

2005:   Postgraduate Travel Award (Mutual Community)

2005:   Member of the CSIRO Total Wellbeing Diet Research Team which was awarded the CSIRO 2005 Research Achievement Award

2004:   Best student presentation prize (Nutrition Society of Australia Adelaide Branch)

2004:   Travel scholarship (Nutrition Society of Australia National Conference)

2002:   PhD scholarship (Australian Postgraduate Award) for University of Adelaide Department of Obstetrics and Gynaecology Faculty of Health Sciences

2002:   CSIRO Industry award for PhD scholarship (CSIRO Health Sciences and Nutrition)

2001:   Honours Research scholarship from North Western Adelaide Health Service

2014: Robinson Research Institute and SRPH Travel Grant

Teaching Interests

2002-13:          Under-graduate and post-graduate teaching: Tutor, Lecturer, Research Supervisor

·         University of Adelaide, Bachelor of Health Science (3rd year)

·         Monash University, Bachelor of Medicine and Surgery (3rd year)

·         University of Adelaide, Bachelor of Dentistry (1st year Dentistry)

·         University of Adelaide, Bachelor of Science (2nd year Physiology)

·         Flinders University, Bachelor and Masters of Nutrition and Dietetics

Research Interests

Dr Moran’s current research interests include the assessment and management of obesity-related health for women with conditions conferring an increased risk of disease or at life stages where treatment can be strategically targeted to optimise health including women with polycystic ovary syndrome and prior to, during and following pregnancy.

Research Funding

2012:   National Health and Medical Research Council Project Grant (Category 1).

Amount: $673,008. 86. Chief Investigators: Dodd J, McPhee A, Moran L, Yelland L, Gillman M, Lawlor D, Robinson J.

2012:   University of Adelaide Faculty of Health Science New Appointment Funding.

            Amount: $12,000. Chief Investigator: Moran LJ

2012:   Foundation for Children.

            Amount: $79,474. Chief Investigators: Moran LJ, Dodd J, Grivell R

2012-15: Heart Foundation Cardiovascular Research Development Fellowship and Project Grant

(Category 1). Amount $450,000. Chief Investigators: Moran LJ

2011:   Diabetes Australia Research Trust (Category 1).

            Amount  $39,769.50. Chief Investigators: Moran LJ, Dodd J, Owens J, Robinson J

2011:   Australian Federation of University Women Postdoctoral Grants.

Amount $4795. Chief Investigators: Moran LJ

2011:   New Directions Funding Scheme, Robinson Institute, The University of Adelaide.

Amount $10,000. Chief Investigators: Dodd J, Grivell R, Moran L

2008-11: National Health and Medical Research Council Biomedical Post-Doctoral Fellowship (Category

1)      Amount $270,000. Chief Investigators: Moran LJ

2009:   The Jean Hailes Foundation for Women’s Health Clinical Research Funding.

Amount $16,500; Chief Investigators: Moran LJ

2007:   Diabetes Australia Research Trust (Category 1).

            Amount: $47,500; Chief Investigators: Moran LJ, Teede HJ

2003:   University of Adelaide Reproductive Medicine Unit Grants for Clinically Based Research Funding. Amount: $50,000; Chief Investigators: Moran LJ, Norman RJ

Publications

Original Research Publications

1.      Joham AE, Ranasinha S, Zoungas S, Moran L, Loxton D, Teede HJ. Gestational Diabetes and Type 2 Diabetes in Reproductive-Aged Women with Polycystic Ovary Syndrome. Journal of Clinical Endocrinology and Metabolism, in press (accepted 9/8/2013).

2.      Sui Z, Moran L, Chapple L, Dodd J. 2013. Agreement Between a Food Frequency Questionnaire and the Willett Questionnaire in Overweight or Obese Pregnant Women. Journal of Nutritional Therapeutics, in press (accepted 1/7/13).

3.      Moran LJ, Teede HJ, Noakes M, Clifton PM, Norman RJ and Wittert GA. 2013, SHBG, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome. Journal of Endocrinological Investigation, in press (accepted 3/06/2013).

4.      Moran LJ, Ranasinha S, Zoungas S, McNaughton SA, Brown WJ, Teede HJ. 2013, The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome. Human Reproduction, in press (accepted 22/05/2013).

5.      Teede HJ, Ng S, Hedger M, Moran L. 2013, Follistatin and activins in Polycystic Ovary Syndrome: Relationship to metabolic and hormonal markers Metabolism, In press (accepted 8/5/2013).

6.      Moran LJ, Wilson CC, Buckley JD, Noakes M, Clifton PM, Brinkworth GD. 2013. Changes in endothelial function and depression scores are associated following long-term dietary intervention: a secondary analysis. Nutrition, In press (accepted 27/3/13).

7.      Teede HJ, Joham AE, Paul E, Moran LJ, Loxton D, Jolley D, Lombard C. 2012. Longitudinal weight gain in women identified with Polycystic Ovary Syndrome: Results of an observational study in young women. Obesity, In press (accepted 15/11/12). [IF=4.284, ranked 9/75 in Dietetics]

8.      Kozica S, Gibson-Helm M, Teede H, Moran L. 2012. Assessing self-efficacy and self-help methods in women with and without polycystic ovary syndrome. Behavioral Medicine, In press (accepted 2/8/2012). [IF=1.143, ranked 89/129 in Psychiatry]

9.      Moran LJ, Sui Z, Cramp CS, Dodd JM. 2012. A decrease in diet quality occurs during pregnancy in overweight and obese women which is maintained post-partum. International Journal of Obesity, In press, (accepted 3/7/2012). [IF=4.691, ranked 24/121 in Endocrinology and Metabolism]

10.  Moran LJ, Noakes M, Wittert GA, Clifton PM, Norman RJ. 2012. Weight loss and vascular inflammatory markers in overweight women with and without polycystic ovary syndrome. Reproductive Biomedicine Online, 25 (5): 500-3. IF=2.042, ranked 25/79 in Obstetrics and Gynecology]

11.  Moran LJ, Deeks AA, Gibson-Helm M, Teede HJ. 2012. Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome. Human Reproduction, 27(2): 2082-8 [IF=3.859, ranked 3/26 in Reproductive Biology]

12.  Kozica SK, Deeks AA, Gibson-Helm M, Teede HJ, Moran LJ. 2012. Health related behaviors in women with lifestyle related diseases, associated with physical inactivity and diet. Behavioral Medicine, 38(3): 65-73. [IF=1.143, ranked 89/129 in Psychiatry]

13.  Moran LJ, Harrison CL, Hutchison SK, Stepto NK, Strauss BJ, Teede HJ. 2011, Exercise decreases anti-müllerian hormone in anovulatory overweight women with Polycystic Ovary Syndrome – A pilot study. Hormone and Metabolic Research, 43(13): 977-9. [IF=2.414, ranked 67/166 in Endocrinology and Metabolism] (Times cited: 1)

14.  Moran LJ, Tsagareli V, Norman RJ, Noakes. 2011, Diet and IVF Approaches (DIVA) pilot study: Short-term weight loss improves pregnancy rates in overweight / obese women undertaking IVF. Australian and New Zealand Journal of Obstetrics and Gynaecology, 51 (5): 455-9. [IF=1.184, ranked 54/74 in Obstetrics and Gynaecology] (Times cited: 4)

15.  Moran LJ, Cameron JD, Strauss BJ, Teede HJ. 2011, Vascular function in the diagnostic categories of PCOS. Human Reproduction, 26 (8): 2192-9. [IF=3.859, ranked 3/26 in Reproductive Biology] (Times cited: 2)

16.  Moran LJ, Strauss BJ, Teede HJ. 2011, Diabetes Risk Score in the diagnostic categories of PCOS. Fertility and Sterility, 95 (5): 1742-8.  [IF=3.970, ranked 2/26 in Reproductive Biology] (Times cited: 6)

17.  Hutchison SK, Stepto NK, Harrison C, Moran LJ, Strauss B, Teede HJ. 2011, Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome. J Clin Endocrinol Metab, 96 (1): E48-56. [IF=6.202, ranked 10/105 in Endocrinology and Metabolism] (timed cited: 11)

18.  Moran LJ, Noakes M, Clifton PM, Norman RJ. 2010, The effect of modifying dietary protein and carbohydrate in weight loss on arterial compliance and postprandial lipidaemia in overweight women with polycystic ovary syndrome. Fertility and Sterility, 94 (6): 2451-4. [IF=3.970, ranked 2/26 in Reproductive Biology] (Times cited: 1)

19.  Moran LJ, Gibson-Helm ME, Teede HJ, Deeks AA. 2010, Polycystic Ovary Syndrome: A biopsychosocial understanding in young women to improve knowledge and treatment options. J Psycho Ob Gy, 31(1): 24-31. [IF=1.197, ranked 47/69 in Obstetrics and Gynaecology] (Times cited: 6)

20.  Teede HJ, Meyer C, Hutchison SK, Zoungas S, McGrath BP, Moran LJ. 2010, Endothelial function and insulin resistance in Polycystic Ovary Syndrome: The effects of medical therapy. Fertility and Sterility, 93 (1): 184-91. [IF=3.970, ranked 2/26 in Reproductive Biology] (Times cited: 13)

21.  Moran LJ , Meyer C, Hutchison SK, Zoungas S, Teede HJ. 2010, Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention. Journal of Endocrinological Investigation, 33: 258-265. [IF=1.347, 87/105 in Endocrinology and Metabolism] (Times cited: 9)

22.  Thomson RL, Buckley JD, Moran LJ, Noakes M, Clifton PM, Norman RJ, Brinkworth GD. 2009, The effect of weight loss on anti-müllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment. Human Reproduction, 24 (8): 1976-81. [IF=3.859, ranked 3/26 in Reproductive Biology]. (Times cited: 16)

23.  Moran LJ, Lombard CB, Noakes M. 2009. Is there a need for Clinical Practice Guidelines for the dietary treatment of women with Polycystic Ovary Syndrome? Nutrition and Dietetics, 66 (4): 249-251. [IF=0.724, ranked 55/66 in Nutrition and Dietetics].

24.  Thomson RL, Buckley JD, Moran LJ, Noakes M, Clifton PM, Norman RJ, Brinkworth GD. 2009, Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome. British Journal of Obstetrics and Gynaecology, 116 (9): 1242-50. [IF=3.437, ranked 6/70 in Obstetrics and Gynaecology]. (Times cited: 7)

25.  Moran LJ, Hutchison SK, Meyer C, Zoungas S, Teede HJ. 2008, A comprehensive assessment of endothelial function in overweight women with and without Polycystic Ovary Syndrome. Clinical Science, 116 (10): 761-70. [IF=3.982, ranked 19/93 in Medicine, Research and Experimental]. (Times cited: 21)

26.  Moran LJ, Noakes M, Clifton P, Norman RJ, Fenech M. 2007, Genome instability is increased in lymphocytes of women with Polycystic Ovary Syndrome and is correlated with insulin resistance. Mutation Research, 639(1-2):55-63. [IF=3.556, ranked 10/77 in Toxicology]. (Times cited: 13)

27.  Moran LJ, Noakes M, Clifton P, Norman RJ. 2007, The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with Polycystic Ovary Syndrome. J Clin Endocrinol Metab, 92(10):3796-802. [IF=6.202, ranked 10/105 in Endocrinology and Metabolism] (Times cited: 11)

28.  Moran LJ, Noakes M, Clifton P, Wittert GA, Le Roux C, Ghatei M, Bloom S, Norman RJ. 2007, Post-prandial ghrelin, cholecystokinin, PYY, appetite and food consumption before and after weight loss in overweight women with and without Polycystic Ovary Syndrome. The American Journal of Clinical Nutrition, 86(6):1603-10. [IF=6.307, ranked 3/66 in Nutrition and Dietetics]. (Times cited: 14)

29.  Galletly C, Moran L, Noakes M, Clifton P, Tomlinson L, Norman R. 2007, Psychological benefits of a high-protein, low-carbohydrate diet in obese women with polycystic ovary syndrome-A pilot study. Appetite, 49(3): 590-3. [IF=2.582, ranked 24/66 Nutrition and Dietetics]. (Times cited: 15)

30.  Moran LJ, Noakes M, Clifton P, Wittert GA, Belobrajdic D, Norman RJ. 2007, C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome. J Clin Endo Metab, 92(8): 2944-51. [IF=6.202, ranked 10/105 in Endocrinology and Metabolism] (Times cited: 29)

31.  Brinkworth GD, Moran LJ, Noakes M, Norman R, Clifton PM. 2006, Flow mediated dilatation in overweight and obese women with polycystic ovary syndrome. British Journal of Obstetrics and Gynaecology, 113: 1308-1314. [IF=3.437, ranked 6/70 in Obstetrics and Gynaecology] (Times cited: 21)

32.  Moran LJ, Noakes M, Clifton PM, Wittert GA, Williams G, Norman RJ. 2006, Short term meal replacements followed by dietary macronutrient restriction enhances weight loss in Polycystic Ovary Syndrome. The American Journal of Clinical Nutrition; 84(1): 77-87. [IF=6.307, ranked 3/66 in Nutrition and Dietetics] (Times cited: 37)

33.  Moran LJ, Luscombe-Marsh ND, Noakes M, Wittert GA, Keogh JB, Clifton PM. 2005, The satiating effect of dietary protein is unrelated to post-prandial ghrelin secretion. J Clin Endocrinol Metab; 90(9):5205–21. [IF=6.202, ranked 10/105 in Endocrinology and Metabolism] (Times cited: 35)

34.  Moran LJ, Noakes M, Clifton PM, Wittert G, Tomlinson L, Galletly C, Luscombe N, Tomlinson L, Norman RJ. 2004, Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. J Clin Endocrinol Metab 89(7):3337-44. [IF=6.202, ranked 10/105 in Endocrinology and Metabolism] (Times cited: 62)

35.  Moran LJ, Noakes M, Clifton PM, Tomlinson L, Galletly C, Norman RJ. 2003, Dietary composition in restoring reproductive and metabolic parameters in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 88(2): 812-9. [IF=6.202, ranked 10/105 in Endocrinology and Metabolism] (Times cited: 211)

 

Invited reviews

36.  Moran LJ, Norman RJ. 2012. The effect of bariatric surgery on female reproductive function. J Clin Endocrinol Metab. 97(12):4352-4. [IF=6.202, ranked 10/105 in Endocrinology and Metabolism].

37.  Lim SS, Davies MJ, Norman RJ, Moran LJ. 2012. Overweight, obesity and central obesity in PCOS women: A systematic review and meta-analysis. Human Reproduction Update, 18 (6): 618-637. [IF=7.042, ranked 1/26 in Reproductive Biology]

38.  Moran LJ, Dodd J, Nisenblat V, Norman R. 2011. Obesity and Reproductive Dysfunction in Women. Endocrinology and Metabolism Clinics of North America, 40 (4): 895-906. [IF=3.562, ranked 35/105 in Endocrinology and Metabolism] (Times cited: 1)

39.  Harrison C, Lombard C, Moran L, Teede HJ. 2011. Exercise Therapy in Polycystic Ovary Syndrome: A Systematic Review. Human Reproduction Update, 17 (2): 171-83. [IF=7.042, ranked 1/26 in Reproductive Biology] (Times cited: 6)

40.  Moran LJ, Misso M, Wild R, Norman RJ. 2010, Impaired glucose tolerance, Type 2 Diabetes and Metabolic Syndrome in Polycystic Ovary Syndrome: A systematic review and meta-analysis. Human Reproduction Update, 16(4):347-63. [IF=7.042, ranked 1/26 in Reproductive Biology]  (Times cited: 54)

41.  Moran LJ, Lombard CB, Lim S, Noakes M, Teede HJ. 2010, Polycystic ovary syndrome and weight management. Women’s Health, 6(2); 271-83. [IF=7.042, ranked 1/26 in Reproductive Biology] (Times cited: 11)

42.  Moran LJ, Teede HJ. 2009, Metabolic features of the reproductive phenotypes of Polycystic Ovary Syndrome. Human Reproduction Update, 15(4): 477-88. [IF=7.042, ranked 1/26 in Reproductive Biology] (Times cited: 50)

43.  Moran LJ, Brinkworth G, Norman RJ. 2007. Dietary therapy in polycystic ovary syndrome. Seminars in Reproductive Medicine. 26(1):85-92. [IF=3.051, ranked 6/26 in Reproductive Biology]. (Times cited: 14)

44.  Moran LJ, Noakes M, Brinkworth G, Norman RJ. 2006, Effects of lifestyle modification in polycystic ovarian syndrome. Reproductive BioMedicine Online, 12(5); 569-578. [IF=2.380, ranked 16/70 in Obstetrics and Gynaecology] (Times cited: 40)

 

Reviews

45.  Moran LJ, Ko H, Misso M, Marsh K, Noakes M, Talbot M, Frearson M, Thondan M, Stepto N, Teede HJ.  2013. Dietary composition in the treatment of polycystic ovary syndrome: A systematic review to inform evidence based guidelines. Journal of the Academy of Nutrition and Dietetics. 113(4):520-45. [IF=3.586, ranked 17/74 in Nutrition and Dietetics]

46.  Lim SS, Norman RJ, Davies MJ, Moran LJ. 2012. The effect of obesity on polycystic ovary syndrome: A systematic review and meta-analysis. Obesity Reviews. 14(2):95-109. [IF=7.038, ranked 10/121 in Endocrinology and Metabolism]

47.  Wycherley TP, Moran LJ, Clifton PM, Noakes M, Brinkworth GD. 2012. Effects of energy restricted high protein, low fat vs. standard protein, low fat diets: A meta-analysis of randomized controlled trials. Am J Clin Nutr. 96(6):1281-98. [IF=6.307, ranked 3/66 in Nutrition and Dietetics]

48.  Garad R, Teede HJ, Moran LJ.  2011. An evidence-based guideline for Polycystic Ovary Syndrome.  Australian Nurses Journal. 19 (4): 32-33.

49.  Teede HJ, Misso ML, Deeks AA, Moran LJ, Stuckey BGA, Wong JLA, Norman RJ, Costello MF. 2011. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline.  Medical Journal of Australia,195(6):S1-48. [IF=2.684, ranked 27/155 in Medicine, General and Internal] (Times cited: 10)

50.  Moran LJ, Hutchison SK, Norman RJ, Teede HJ. 2011, Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews, Jul 6 (7): CD007506. [IF=6.186, ranked 10/155 in Medicine, General and Internal]. (Times cited: 12)

51.  Teede HJ, Deeks A, Moran LJ. 2010, Polycystic Ovary Syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Medicine, 30 (8): 41. [IF=3.985, ranked 18/133 in Medicine, General and Internal] (Times cited: 46)

52.  Moran LJ, Pasquali R, Teede HJ, Hoeger, KM, Norman RJ. 2008, Androgen Excess and Polycystic Ovary Syndrome Society Position Statement: Treatment of obesity in Polycystic Ovary Syndrome. Fertility and Sterility, 92(6): 1966-82. [IF=3.985, ranked 18/133 in Medicine, General and Internal](Times cited: 48)

53.  Teede HJ, Moran LJ, Deeks A. 2008, Obesity and lifestyle. Medical observer, June 6.

54.  Moran LJ, Hutchison SK, Norman RJ, Teede HJ. 2008, Lifestyle changes for overweight women with Polycystic Ovary Syndrome. Cochrane Protocol, 4: 1-10. [IF=6.186, ranked 10/155 in Medicine, General and Internal].

55.  Moran L, Teede H. 2007, Diet and Insulin Resistance. Cardiology in General Practice. 2: 28.

56.  Norman RJ, Homan G, Moran L, Noakes M. 2006, Lifestyle choices, diet and insulin sensitisers in polycystic ovary syndrome. Endocrine, 30(1): 35-43. [IF=1.278, ranked 88/105 in Endocrinology and Metabolism] (Times cited: 6)

57.  Moran L and Norman RJ. 2004, Understanding and managing disturbances in insulin metabolism and body weight in overweight women with polycystic ovary syndrome. Best Practice and Research Clinical Obstetrics and Gynaecology. 18(5):719-36. [IF=1.867, ranked 29/70 in Obstetrics and Gynaecology] (Times cited: 43)

58.  Norman RJ, Noakes M, Wu Ruijin, Davies MJ, Moran L, Wang JX. 2004, Improving reproductive performance in overweight/obese women with effective weight management. Human Reproduction Update, Vol 10 (3): 267 – 280. [IF=7.042, ranked 1/26 in Reproductive Biology]  (Times cited: 139)

59.  Moran LJ, Norman RJ. 2002, The obese patient with infertility: a practical approach to diagnosis and treatment. Nutrition in Clinical Care 5(6): 290 – 9. (Times cited: 23)

60.  Norman RJ, Davies MJ, Lord J, Moran LJ. 2002, The role of lifestyle modification in polycystic ovary syndrome. Trends in Endocrinology and Metabolism 13(6): 251 – 7. [IF=6.562, ranked 8/105 in Endocrinology and Metabolism] (Times cited: 119)

61.  Norman RJ, Moran L, Davies MJ. 2001, Nutritional aspects of polycystic ovary syndrome. Reproductive Medicine Reviews 9(2): 91 – 107.

 

Book chapters

62.  Norman RJ, Moran LJ, Robertson SA. 2011, Lifestyle, periconception and fertility. Textbook of Assisted Reproductive Technologies, 3rd edition (accepted 18th August 2011). Informa Health Care.

63.  Moran LJ, Norman RJ. 2010, Do Vitamins/ natural supplements improve pregnancy rates. IVF Success, 38-42. Cambridge University Press.

64.  Teede HJ, Moran LJ, Deeks A. 2008, Polycystic ovary syndrome. Australian Doctor, 29 Aug. 25-32.

65.  Norman RJ, Ruifrok AE, Moran LJ, Robker R. 2007, Recommended therapies for metabolic defects in Polycystic Ovary Syndrome. Chapter 16, pages 259-79. Contemporary Endocrinology: Polycystic Ovary Syndrome, Humana Press.

66.  Norman RJ, Moran L. 2007. Lifestyle factors in the etiology and management of Polycystic Ovary Syndrome.  Chapter 9, pages 121-139. Polycystic Ovary Syndrome (Second Edition) Cambridge University Press.

67.  Noakes M, Brinkworth G, Moran L, Norman RJ. 2007, Weight Reduction and Life-Style Modification in the Treatment of Androgen Excess. Pages 435-443. Androgen Excess Disorders in Women – Contemporary Endocrinology. Humana Press.

68.  Norman RJ, Hickey T, Moran L, Boyle J, Wang J, Davies M. 2004, Polycystic ovary syndrome – diagnosis and etiology. International Congress Series 1266; 225 – 232. Elsevier.

 

Evidence based guidelines

69.  Evidence based guidelines for assessment and management of polycystic ovary syndrome. Melbourne: Jean Hailes Foundation for Women’s Health and PCOS Australian Alliance, 2011.

Professional Associations

Membership of Healthy Development Adelaide

Membership of the Australian National Association of Research Fellows

Membership of Androgen Excess Society

Membership of Nutrition Society of Australia

Membership of Endocrine Society of Australia

Membership of Australian and New Zealand Society for the Study of Obesity

Professional Interests

Dr Moran has expertise in human clinical trials in obesity, insulin resistance and polycystic ovary syndrome involving short and long-term dietary weight loss and maintenance interventions, manipulation of macronutrient composition and assessment of acute appetite regulation, energy expenditure and subclinical markers of atherosclerosis. She has clinical and laboratory experience including non-invasive assessment of vascular function, euglycaemic hyperinsulinaemic clamps, hormone and enzyme immunoassays and cytogenetics. She has expertise in evidence-based medicine including systematic reviews, meta-analysis and Cochrane reviews and national guideline development.

Community Engagement

Dr Moran is a nationally and internationally recognised researcher in the field of lifestyle management, reproductive health and PCOS. I have also provided a leadership role in translation of key research findings in the field of Lifestyle Interventions and Women’s Health to consumers, medical and Allied Health professionals and policy makers. I have ongoing commitment to consumer and health professional education on PCOS through The Jean Hailes Foundation for Women’s Health and am regularly consulted as a liasion for the education unit.

2013: Invited speaker at community and health professional forums for Healthy Development Adelaide, the Fertility Society of Australia and Your Fertility on optimal preconception health education resources.

2013: Invited member of the NHMRC Research Translation Faculty.

2012: Invited member of the Your Fertility Initiative: Federally funded by the Department of Health and aging to develop consumer and professional education programs to improve advice provision regarding optimising fertility and options for reproductive health assistance.

2011-12: Invited contributor to The Fertility Association of Australia Guidelines for Preconception Health.

2009-11: Invited chair of the NHMRC funded National Lifestyle Intervention Evidence Based Guidelines team for PCOS.

2008: Key role in the development of the PCOS Australian Alliance which is an Australian organisation comprising researchers, clinicians and consumers with an interest in PCOS. The PCOS Alliance brings together national clinical and research expert opinion on the assessment and treatment of PCOS with the aim of influencing National Guideline Development.

2007-11: Lead author of The Jean Hailes Foundation Managing PCOS website which provides evidence-based information on the background, implications and treatment of PCOS to consumers and health professionals.

2007-11: Publication in specialist nursing, dietetic and GP journals and Cochrane Reviews on the treatment of PCOS.

2007:  Invited leader of an international position statement on lifestyle intervention in PCOS for the International Androgen Excess PCOS Society which provides evidence-based information on lifestyle management of PCOS.

2007: Significant role in the development of GP guidelines for the treatment of PCOS through the GP Check Program

2006-9: Invited presenter at international PCOS research meetings to update clinicians and researchers on lifestyle management of PCOS to guide evidence-based practice (Androgen Excess Society Greece 2006, Asia Pacific PCOS Meeting Hong Kong 2009)

Entry last updated: Tuesday, 12 Apr 2016

The information in this directory is provided to support the academic, administrative and business activities of the University of Adelaide. To facilitate these activities, entries in the University Phone Directory are not limited to University employees. The use of information provided here for any other purpose, including the sending of unsolicited commercial material via email or any other electronic format, is strictly prohibited. The University reserves the right to recover all costs incurred in the event of breach of this policy.